Apr 24, 2008 - Research and Markets (http://www.researchandmarkets.com/reports/c89861) has announced the addition of Commercial and Pipeline Insight: Opioids - Short acting and anti-abuse technologies set to fragment and grow the market to their offering.
The opioid market is currently valued at $7.7 billion and is set to increase over the next 10 years at a CAGR of 2.4%. Despite this market being exclusively comprised of old genericized molecules, novel formulations and delivery methods have stimulated growth over the last 5 years. This growth is set to continue as current market players instigate lifecycle management strategies to retain value.
(source: www.pharmalive.com)
No comments:
Post a Comment